These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 18240233

  • 1. Association between treatment with central nervous system stimulants and Raynaud's syndrome in children: a retrospective case-control study of rheumatology patients.
    Goldman W, Seltzer R, Reuman P.
    Arthritis Rheum; 2008 Feb; 58(2):563-6. PubMed ID: 18240233
    [Abstract] [Full Text] [Related]

  • 2. Methylphenidate and dextroamphetamine-induced peripheral vasculopathy.
    Syed RH, Moore TL.
    J Clin Rheumatol; 2008 Feb; 14(1):30-3. PubMed ID: 18431096
    [Abstract] [Full Text] [Related]

  • 3. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.
    Varley CK, Vincent J, Varley P, Calderon R.
    Compr Psychiatry; 2001 Feb; 42(3):228-33. PubMed ID: 11349243
    [Abstract] [Full Text] [Related]

  • 4. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
    Findling RL, Wigal SB, Bukstein OG, Boellner SW, Abikoff HB, Turnbow JM, Civil R.
    Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
    [Abstract] [Full Text] [Related]

  • 5. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B, Sopko MA, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT.
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [Abstract] [Full Text] [Related]

  • 6. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL.
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [Abstract] [Full Text] [Related]

  • 7. Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Winterstein AG, Gerhard T, Shuster J, Johnson M, Zito JM, Saidi A.
    Pediatrics; 2007 Dec; 120(6):e1494-501. PubMed ID: 18055666
    [Abstract] [Full Text] [Related]

  • 8. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
    Walitza S, Kämpf K, Artamonov N, Romanos M, Gnana Oli R, Wirth S, Warnke A, Gerlach M, Stopper H.
    Toxicol Lett; 2009 Jan 10; 184(1):38-43. PubMed ID: 19015014
    [Abstract] [Full Text] [Related]

  • 9. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA, Pliszka SR.
    Pharmacotherapy; 2009 Jun 10; 29(6):656-79. PubMed ID: 19476419
    [Abstract] [Full Text] [Related]

  • 10. Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial.
    Golubchik P, Sever J, Zalsman G, Weizman A.
    Int Clin Psychopharmacol; 2008 Jul 10; 23(4):228-31. PubMed ID: 18446088
    [Abstract] [Full Text] [Related]

  • 11. [Raynaud phenomenon as adverse effect of ADHD treatment].
    Lakartidningen; 2008 Jul 10; 105(50):3662-3. PubMed ID: 19177933
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children.
    Kociancic T, Reed MD, Findling RL.
    Expert Opin Drug Saf; 2004 Mar 10; 3(2):93-100. PubMed ID: 15006715
    [Abstract] [Full Text] [Related]

  • 13. The use of imipramine in Tourette's syndrome and attention deficit disorder: case report.
    Dillon DC, Salzman IJ, Schulsinger DA.
    J Clin Psychiatry; 1985 Aug 10; 46(8):348-9. PubMed ID: 2862138
    [Abstract] [Full Text] [Related]

  • 14. Influence of stimulants on electrodermal studies in Fragile X syndrome.
    Hagerman RJ, Miller LJ, McGrath-Clarke J, Riley K, Goldson E, Harris SW, Simon J, Church K, Bonnell J, Ognibene TC, McIntosh DN.
    Microsc Res Tech; 2002 May 01; 57(3):168-73. PubMed ID: 12112453
    [Abstract] [Full Text] [Related]

  • 15. Systemic sclerosis induced by CNS stimulants for ADHD: A case series and review of the literature.
    Meridor K, Levy Y.
    Autoimmun Rev; 2020 Jan 01; 19(1):102439. PubMed ID: 31734401
    [Abstract] [Full Text] [Related]

  • 16. A controlled study of autonomic nervous system function in adults with attention-deficit/hyperactivity disorder treated with stimulant medications: results of a pilot study.
    Schubiner H, Hassunizadeh B, Kaczynski R.
    J Atten Disord; 2006 Nov 01; 10(2):205-11. PubMed ID: 17085631
    [Abstract] [Full Text] [Related]

  • 17. Risperidone-to-methylphenidate switch reaction in children: three cases.
    Sabuncuoglu O.
    J Psychopharmacol; 2007 Mar 01; 21(2):216-9. PubMed ID: 17329303
    [Abstract] [Full Text] [Related]

  • 18. Association between homozygosity of a G allele of the alpha-2a-adrenergic receptor gene and methylphenidate response in Korean children and adolescents with attention-deficit/hyperactivity disorder.
    Cheon KA, Cho DY, Koo MS, Song DH, Namkoong K.
    Biol Psychiatry; 2009 Apr 01; 65(7):564-70. PubMed ID: 19150055
    [Abstract] [Full Text] [Related]

  • 19. An analysis of patient adherence to treatment during a 1-year, open-label study of OROS methylphenidate in children with ADHD.
    Faraone SV, Biederman J, Zimmerman B.
    J Atten Disord; 2007 Sep 01; 11(2):157-66. PubMed ID: 17494833
    [Abstract] [Full Text] [Related]

  • 20. Ingestion of stimulant medications does not alter bispectral index or clinical depth of anesthesia at 1 MAC sevoflurane in children.
    Chambers NA, Pascoe E, Kaplanian S, Forsyth I.
    Paediatr Anaesth; 2012 Apr 01; 22(4):341-4. PubMed ID: 21988202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.